Literature DB >> 10588086

Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.

K A Hennessey1, N Ion-Nedelcu, M D Craciun, F Toma, W Wattigney, P M Strebel.   

Abstract

A measles epidemic occurred in Romania with 32,915 cases and 21 deaths reported between November 1996 and June 1998, despite high vaccination coverage since the early 1980s. Most cases were unvaccinated children aged <2 years and vaccinated school-aged children. A case-control study among preschool children and a cohort study among primary-school children were conducted to estimate effectiveness of Romanian-produced measles vaccine, and to evaluate age at vaccination and waning immunity as risk factors for vaccine failure. Both studies indicated that measles vaccine was highly effective. One dose reduced the risk for measles by 89% (95% confidence interval (CI) 85, 91); two doses reduced the risk by 96% (95% CI 92, 98). Children vaccinated at <1 year of age were not at increased risk for measles compared with children vaccinated at > or =1 year. Waning immunity was not identified as a risk factor since vaccine effectiveness was similar for children vaccinated 6-8, 9-11, and 12-14 years in the past. Because specific groups were not at risk for vaccine failure, an immunization campaign that targets all school-aged children who lack two doses may be an effective strategy for preventing outbreaks. A mass campaign followed by increased first-dose coverage should provide the population immunity required to interrupt indigenous measles virus transmission in Romania.

Entities:  

Keywords:  Age Factors; Biology; Case Control Studies; Child; Communicable Disease Control; Delivery Of Health Care; Demographic Factors; Developed Countries; Diseases; Eastern Europe; Europe; Health; Health Services; Immunization; Measles--prevention and control; Population; Population Characteristics; Primary Health Care; Research Methodology; Research Report; Risk Factors; Romania; Studies; Vaccines; Viral Diseases; Youth

Mesh:

Substances:

Year:  1999        PMID: 10588086     DOI: 10.1093/oxfordjournals.aje.a009952

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  6 in total

1.  Measles eradication: is it in our future?

Authors:  W A Orenstein; P M Strebel; M Papania; R W Sutter; W J Bellini; S L Cochi
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

2.  Measles elimination: a mass immunization campaign in Romania.

Authors:  N Ion-Nedelcu; D Craciun; D Pitigoi; M Popa; K Hennessey; C Roure; R Aston; G Zimmermann; M Pelly; N Gay; P Strebel
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

3.  Age-specific mixing generates transient outbreak risk following critical-level vaccination.

Authors:  S Bhattacharyya; M J Ferrari
Journal:  Epidemiol Infect       Date:  2016-09-28       Impact factor: 4.434

4.  Characterisation of measles after the introduction of the combined measles-mumps-rubella (MMR) vaccine in 2004 with focus on the laboratory data, 2016 to 2019 outbreak, Romania.

Authors:  Mihaela Lazar; Aurora Stănescu; Ana Raquel Penedos; Adriana Pistol
Journal:  Euro Surveill       Date:  2019-07

Review 5.  The effect of time since measles vaccination and age at first dose on measles vaccine effectiveness - A systematic review.

Authors:  Stephanie L Hughes; Shelly Bolotin; Sumaiya Khan; Ye Li; Caitlin Johnson; Lindsay Friedman; Andrea C Tricco; Susan J M Hahné; Jane M Heffernan; Alya Dabbagh; David N Durrheim; Walter A Orenstein; William J Moss; Mark Jit; Natasha S Crowcroft
Journal:  Vaccine       Date:  2019-11-12       Impact factor: 3.641

6.  Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis.

Authors:  Sara Carazo; Marie-Noëlle Billard; Amélie Boutin; Gaston De Serres
Journal:  BMC Infect Dis       Date:  2020-03-29       Impact factor: 3.090

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.